Search research articles
Contact Us
Filters
Showing results (21-30 of 67) with videos related to
Page
of 7
Sort By:
Thyroid : Official Journal of the American Thyroid Association
|
February 15, 2018
Effect of Thyroglobulin Autoantibodies on the Metabolic Clearance of Serum Thyroglobulin
Francesco Latrofa, Debora Ricci, Sara Bottai, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
June 30, 2015
ABSENCE OF A THYROID PHENOTYPE IN SORTILIN-DEFICIENT MICE
Simonetta Lisi, Peder Madsen, Roberta Botta, et al.
Annals of Internal Medicine
|
September 11, 2003
Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens
Luca Chiovato, Francesco Latrofa, Lewis E Braverman, et al.
European Thyroid Journal
|
October 27, 2017
Does Graves' Orbitopathy Ever Disappear? Answers to an Old Question
Elena Sabini, Marenza Leo, Barbara Mazzi, et al.
European Thyroid Journal
|
October 12, 2019
Graves' Disease Induced by Immune Checkpoint Inhibitors: A Case Report and Review of the Literature
Alessandro Brancatella, Nicola Viola, Sandra Brogioni, et al.
The Journal of Clinical Investigation
|
July 18, 2002
Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor
Gregorio D Chazenbalk, Pavel Pichurin, Chun-Rong Chen, et al.
European Thyroid Journal
|
October 8, 2024
Role of genetics and epigenetics in Graves' orbitopathy
Michele Marinò, Giovanna Rotondo Dottore, Francesca Menconi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 22, 2007
Characterization of thyroglobulin epitopes in patients with autoimmune and non-autoimmune thyroid diseases using recombinant human monoclonal thyroglobulin autoantibodies
Francesco Latrofa, Debora Ricci, Lucia Grasso, et al.
Journal of the Endocrine Society
|
July 13, 2023
Significance of Thyroglobulin Autoantibodies in Patients With Thyroid Cancer Treated With Lenvatinib
Daniele Sgrò, Piercarlo Rossi, Paolo Piaggi, et al.
Molecular and Clinical Oncology
|
February 23, 2018
A patient with MEN1 and end-stage chronic kidney disease due to Alport syndrome: Decision making on the eligibility of transplantation
Antonio Matrone, Alessandro Brancatella, Piero Marchetti, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 67) with videos related to
Sort By:
Page
of 7
Thyroid : Official Journal of the American Thyroid Association
|
February 15, 2018
Effect of Thyroglobulin Autoantibodies on the Metabolic Clearance of Serum Thyroglobulin
Francesco Latrofa, Debora Ricci, Sara Bottai, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
June 30, 2015
ABSENCE OF A THYROID PHENOTYPE IN SORTILIN-DEFICIENT MICE
Simonetta Lisi, Peder Madsen, Roberta Botta, et al.
Annals of Internal Medicine
|
September 11, 2003
Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens
Luca Chiovato, Francesco Latrofa, Lewis E Braverman, et al.
European Thyroid Journal
|
October 27, 2017
Does Graves' Orbitopathy Ever Disappear? Answers to an Old Question
Elena Sabini, Marenza Leo, Barbara Mazzi, et al.
European Thyroid Journal
|
October 12, 2019
Graves' Disease Induced by Immune Checkpoint Inhibitors: A Case Report and Review of the Literature
Alessandro Brancatella, Nicola Viola, Sandra Brogioni, et al.
The Journal of Clinical Investigation
|
July 18, 2002
Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor
Gregorio D Chazenbalk, Pavel Pichurin, Chun-Rong Chen, et al.
European Thyroid Journal
|
October 8, 2024
Role of genetics and epigenetics in Graves' orbitopathy
Michele Marinò, Giovanna Rotondo Dottore, Francesca Menconi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 22, 2007
Characterization of thyroglobulin epitopes in patients with autoimmune and non-autoimmune thyroid diseases using recombinant human monoclonal thyroglobulin autoantibodies
Francesco Latrofa, Debora Ricci, Lucia Grasso, et al.
Journal of the Endocrine Society
|
July 13, 2023
Significance of Thyroglobulin Autoantibodies in Patients With Thyroid Cancer Treated With Lenvatinib
Daniele Sgrò, Piercarlo Rossi, Paolo Piaggi, et al.
Molecular and Clinical Oncology
|
February 23, 2018
A patient with MEN1 and end-stage chronic kidney disease due to Alport syndrome: Decision making on the eligibility of transplantation
Antonio Matrone, Alessandro Brancatella, Piero Marchetti, et al.
Page
of 7